336

Nicotine patch side effects: what’s normal and what isn’t

Reviewed

Abstract cross-section of skin layers with particles diffusing from the surface down to a capillary bed

The commonest side effect of a nicotine patch is a red, itchy area of skin under it. In three placebo-controlled trials of one 24-hour patch, 35 per cent of users reported a reaction at the patch site, against 18 per cent on a placebo patch, and about 6 per cent stopped because of it. Moving the patch to a new site each day is the standard fix. Disturbed sleep and vivid dreams come next, mainly with 24-hour patches; switching to a 16-hour patch is the usual answer. In a review of 92 trials, nicotine replacement also raised the odds of nausea and of palpitations or chest pain, with no increase in heart attacks or deaths. Headache and dizziness were no more common than on placebo, which points to withdrawal as the frequent cause. Stop and seek advice for a spreading or blistering rash, chest pain, an irregular heartbeat or repeated vomiting. Nearly all of this evidence comes from smokers; patches have barely been tested in people who only vape.

The skin reaction: how common it is and what to do

Redness or itching under the patch is the main unwanted effect, and the figures are consistent. The product characteristics for one licensed 24-hour patch report a reaction at the application site in 34.9 per cent of 401 people on the active patch and 17.6 per cent of 391 on placebo. Most reactions were mild and most cleared within 48 hours of removing the patch; the more severe ones took one to three weeks. A meta-analysis of adverse events pooled 32 trials and found the odds of skin irritation nearly three times higher with a patch than with an inert control, and observational studies put the proportion affected at about one in five.

The placebo figure is worth noticing. Almost one in five people reacted to a patch carrying only about an eighth of the nicotine, which suggests that the adhesive and the covered skin account for a good part of the problem. That is why the instructions are about placement: a different site every day, several days before returning to the same area, on clean, dry, hairless skin of the upper arm or trunk, and never on broken or irritated skin.

What is not routine is a rash that spreads beyond the outline of the patch, blisters, hives, or swelling. Isolated cases of all of these appear in the trial record, and a few people became sensitised to nicotine itself, which matters because a sensitised person could then react to other nicotine products. That pattern needs a pharmacist or doctor, not another week of rotating sites.

Sleep, insomnia and vivid dreams

Patches come in 16-hour and 24-hour versions for this reason. A 24-hour patch keeps delivering nicotine overnight, which helps with the early-morning withdrawal many people find hardest and is also more likely to cause side effects. A 16-hour patch comes off at bedtime and delivers nothing overnight.

The measured effect is real and modest. Pooled across 19 trials, the odds of insomnia were about 40 per cent higher on nicotine replacement than on an inert control. In the trials of the 24-hour patch above, insomnia was reported by 6.5 per cent on the patch and 5.4 per cent on placebo, and vivid dreams by somewhere between 1 and 6 per cent, more often than on placebo.

The narrow gap has an explanation: stopping smoking disturbs sleep by itself. Insomnia is an established withdrawal symptom, and increased dreaming is a possible one, so some of what gets blamed on the patch would have happened without it. If nights are the problem, the standard advice is to switch to a 16-hour patch. The cost is a stronger craving on waking, and that trade is a matter of preference.

Nausea, palpitations, headache and dizziness

Two of these are tied to the nicotine. In the pooled trials, the odds of nausea and vomiting were about two-thirds higher on nicotine replacement than on placebo, and the odds of palpitations or chest pain about double. In observational studies roughly 8 per cent of users reported nausea and under 4 per cent reported palpitations or chest pain. The same review found no increase in heart attacks or deaths, and none of the trials that reported serious adverse events found a significant difference.

Headache and dizziness are different. They were no more common on nicotine replacement than on placebo across more than twenty trials each, and in the 24-hour patch trials headache was reported by about 30 per cent of both groups. The patch is often not their cause.

When the dose is too high, the signs are those of mild nicotine poisoning: nausea, vomiting, stomach pain, diarrhoea, headache, sweating, pallor and a racing heart. The usual routes are a patch too strong for what was actually being smoked, or smoking on top of the patch. The response is a lower strength, chosen with a pharmacist, and never a cut patch. If symptoms are marked, take the patch off and rinse the skin with water only; the licence advises against soap, which can increase absorption. The skin underneath goes on releasing nicotine for several hours. A dose an adult tolerates can seriously poison a small child, so fold used patches sticky sides together and dispose of them out of reach.

Who should speak to a doctor or pharmacist first

The 2006 licence for the patch above excluded people who had just had a heart attack or stroke and people with unstable or worsening angina or a severe heart rhythm disorder. The current licence for the equivalent patch no longer does: people in hospital for those conditions are advised to try stopping without medication first and, if that fails, to use a patch under medical supervision. A skin disease that would complicate wearing a patch, and allergy to nicotine or to the patch, remain exclusions. It asks for a careful weighing of risk and benefit in high blood pressure, stable angina, heart failure, poor circulation in the legs, diabetes, an overactive thyroid, kidney or liver impairment and stomach ulcers. Under-18s need a clinician’s recommendation, and in pregnancy the decision belongs with a midwife or doctor.

People who only vape are a separate question, and the evidence is thin. Patches are licensed as an aid to stopping smoking, and the licence says they should not be given to non-smokers or occasional smokers, which leaves someone who only vapes outside its terms. Their doses are written in cigarettes per day, and the trials behind them mostly enrolled people smoking fifteen or more. A 2025 Cochrane review of ways to stop vaping found two small trials, 214 people in all, of combination nicotine replacement against minimal support. Quit rates were no better (risk ratio 0.96, 95% confidence interval 0.73 to 1.25) and the reviewers rated the evidence as very low certainty. No serious adverse events were reported. That is neither proof that patches fail for vapers nor evidence that they help, and the label offers no dose guide for vaping, so strength should be chosen with a pharmacist.

Do patches work? What the evidence says

The Cochrane review of nicotine replacement pooled 133 trials and 64,640 people and found that any form of it raised the chance of still not smoking at six months or more by about 55 per cent compared with placebo or no treatment (risk ratio 1.55, 95% confidence interval 1.49 to 1.61). For patches alone the figure was 1.64. The reviewers judged the evidence high quality. A companion review found that a patch combined with a fast-acting form such as gum or lozenge beat a single product by roughly a further quarter.

It sits alongside a second fact. Reviews of population surveys have found that two-thirds to three-quarters of ex-smokers stopped without medication or professional help. The two findings do not conflict. Trials measure the average effect of adding a drug to a quit attempt among people who volunteer for trials; the population figure reflects how the very large number of unaided attempts eventually turn out.

The practical conclusion is undramatic. Replacement therapy is a legitimate, well-evidenced route, and so is stopping outright. If a patch is working for you, the side effects above are mostly manageable and nothing here is a reason to abandon it.

Why 336 does not use them

336 is built for the second route, and that is a design choice, not a claim that the first one fails. A patch course keeps supplying nicotine and steps it down, typically over about twelve weeks. It trades a short, sharp withdrawal for a longer, milder one, and for many people that is the right trade. Stopping outright puts the withdrawal at the front: in studies of smokers, symptoms peak within the first week and mostly ease over two to four weeks.

Two things should not be overstated. The brain’s adjustment is not finished in days by either route: in an imaging study of 19 smokers, the nicotine receptors that multiply with smoking were clearly raised a week after quitting; the authors concluded that the increase persists for up to a month and is gone by six to twelve weeks, a point at which only six of the smokers were scanned. And patches rarely become a permanent habit. Among clients of English stop-smoking services who had used nicotine replacement and were not smoking four weeks after their quit date, about one in five carried on past twelve weeks and 6 per cent were still using it at a year. What 336 offers is a fixed, short structure with no nicotine in it: fourteen days, hour by hour, and then it ends.

When to see a doctor

  • A rash that spreads beyond the patch outline, blisters, hives or swelling — remove the patch and see a pharmacist or doctor
  • Chest pain, or a persistently racing or irregular heartbeat — remove the patch and seek urgent medical advice
  • Repeated vomiting, cold sweats, pallor, tremor or confusion — possible nicotine overdose
  • Fainting, severe dizziness, or difficulty breathing — call emergency services
  • A patch stuck to, chewed or swallowed by a child or pet — remove it and call poison control or emergency services
  • Pregnancy, a recent heart attack or stroke, or unstable angina — get medical advice before using a patch at all

What 336 does not do

336 sells no nicotine product of any kind, so it has nothing to gain from telling you patches are bad. They work for many people, and the trial evidence for them is strong. The app is cold turkey only, with no nicotine replacement sold or recommended inside it: a 14-day, hour-by-hour timeline that is free for the first 24 hours and then a one-time purchase, not a subscription. It will not tell anyone who is doing well on a patch to stop.

On the quit timeline

Withdrawal symptoms, hour by hour

VANLIGA FRÅGOR

Is it normal for the skin under a nicotine patch to go red and itch?

Yes. In placebo-controlled trials of one 24-hour patch, about 35 per cent of users had redness or itching at the patch site, and most reactions cleared within 48 hours of removal. Use a new site each day and leave several days before reusing one. A rash that spreads beyond the patch outline, blisters or swells should be checked by a pharmacist or doctor.

How long do nicotine patch side effects last?

Most skin reactions settle within 48 hours of taking the patch off; more severe ones have lasted one to three weeks. Nausea and palpitations from too high a dose ease after the patch is removed, though the skin goes on releasing nicotine for several hours. Disturbed sleep may be withdrawal as much as the patch, and withdrawal symptoms mostly ease over two to four weeks.

Should I take my nicotine patch off at night?

If vivid dreams or poor sleep are the problem, the standard advice is to switch to a 16-hour patch, which comes off at bedtime and delivers no nicotine overnight. The cost is a stronger craving on waking. A 24-hour patch suits people whose hardest moment is first thing in the morning. Insomnia is also a withdrawal symptom, so changing patch may not remove it entirely.

What are the signs that a nicotine patch is too strong?

Nausea, vomiting, stomach pain, diarrhoea, headache, sweating, pallor and a racing heart are the signs of mild nicotine excess. It usually means the strength is higher than the amount previously smoked, or that the person is smoking on top of the patch. Remove the patch and ask a pharmacist about a lower strength. Chest pain, confusion or repeated vomiting need urgent medical help.

Can I use nicotine patches to quit vaping?

They are not licensed for it and the evidence is thin. Patches are approved for stopping smoking and dosed by cigarettes per day. A 2025 Cochrane review found two small trials of combination nicotine replacement for stopping vaping; quit rates were no better than minimal support, on very low-certainty evidence, with no serious adverse events. A pharmacist can advise on strength if you want to try.

Do nicotine patches actually work?

Yes, in the sense trials measure. Across 133 trials, nicotine replacement raised the chance of long-term abstinence from smoking by about 55 per cent over placebo or no treatment, and patches alone by about 64 per cent. It is also true that two-thirds to three-quarters of ex-smokers in population surveys stopped unaided. Both findings are sound, and neither settles the question for one person.

Sources

  1. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews (Hartmann-Boyce et al.), 2018.
  2. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tobacco Induced Diseases (Mills et al.), 2010.
  3. Summary of Product Characteristics: Nicotine Transdermal Patch 14 mg/24 hour. Health Products Regulatory Authority, Ireland (marketing authorisation holder Novartis Consumer Health), 2006.
  4. Nicotine patches. Health Service Executive (HSE), Ireland, 2025.
  5. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine & Tobacco Research (Hughes JR), 2007.
  6. What is the best way to use nicotine replacement therapy to quit smoking?. Cochrane Database of Systematic Reviews (plain language summary), 2023.
  7. The Global Research Neglect of Unassisted Smoking Cessation: Causes and Consequences. PLoS Medicine (Chapman and MacKenzie), 2010.
  8. Interventions for quitting vaping. Cochrane Database of Systematic Reviews (Butler et al.), 2025.
  9. β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking. Archives of General Psychiatry (Cosgrove et al.), 2009.
  10. Prevalence and Impact of Long-term Use of Nicotine Replacement Therapy in UK Stop-Smoking Services: Findings From the ELONS Study. Nicotine & Tobacco Research (Shahab et al.), 2016.
  11. Nicotinell TTS 20 Transdermal Patches: Summary of Product Characteristics (text revised April 2025). electronic medicines compendium (emc), UK, 2025.

More answers

Ladda ner 336

Få timme-för-timme-vägledning, push-notisbriefingar och ljudcoachning levererat till din telefon.

GOOGLE PLAYAPP STORE